Lyme disease

Current Opinion in Rheumatology

Volumn 11, Issue 4, 1999, Pages 281-288

  Evans, Janine ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNITY; BORRELIA BURGDORFERI; BRAIN DISEASE; CLINICAL FEATURE; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; IXODES; LYME DISEASE; PRIORITY JOURNAL; VACCINATION;

ADULT; BORRELIA BURGDORFERI GROUP; HUMANS; LYME DISEASE;

EID: 0032865927     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199907000-00010     Document Type: Article

References (62)

1. 1 Walker DH: Tick-transmitted infectious diseases in the United States. Ann Rev Public Health 1998, 19:237-269.
2. 2 Anonymous: Lyme disease crosses Pacific. JAMA 1998, 279:1429.
3. 3 Rahn DW, Felz MW: Lyme disease update. Postgraduate Medicine 1998, 103:51-59, 63-64.
4. 4 Cimmino MA: Relative frequency of Lyme Borreliosis and of its clinical manifestations in Europe. Infection 1998, 26:298-300.
5. 5 Young JD: Underreporting of Lyme disease. N Engl J Med 1998, 338:1629.
6. 6 Campbell GL, Fritz CL, Fish D, Nowakowski J, Nadelman RB, Wormser GP: Estimation of the incidence of Lyme disease. Am J Epidemiology 1998, 148:1018-1026. The authors developed a model to estimate the frequency of Ixodes scapularis tick bites and the incidence of Lyme disease in endemic areas. They then applied it to a highly endemic area and concluded that the current method of passive surveillance underestimates the incidence of LD by severalfold.
7. 7 Orioski KA, Campbell GL, Genese CA, Beckley JW, Schriefer ME, Spitainy KC, Dennis DT.: Emergence of Lyme disease in Hunterdon County, New Jersey, 1993: A case-controlled study of risk factors and evaluation of reporting patterns. Am J Epidemiology 1998, 147:391-397.
8. 8 Stafford KC, Cartter ML, Magnarelli LA, Ertel S, Mshar PA: Temporal correlations between tick abundance and prevalence of ticks infected with Borrelia burgdorferi and increasing incidence of Lyme disease. J Clin Micro 1998, 36:1240-1244.
9. 9 Cromley EK, Cartter ML, Mrozinski RD, Ertel S: Residential setting as a risk factor for Lyme disease in a hyperendemic region. Am J Epidemiology 1998, 147:472-477.
10. 10 Herrington JE, Campbell GL, Bailey RE, Cartter ML, Adams M, Frazier EL, Damrow TA, Gensheimer KF: Predisposing factors for individuals' Lyme disease prevention practices: Connecticut, Maine, and Montana. Am J Public Health 1998, 87:2035-2038.
11. 11 Katavolos P, Armstrong PM, Dawson JE, Telford SR: Duration of tick attachment required for transmission of Granulocytic Ehrlichiosis. J Infect Dis 1998, 177:1422-1425.
12. 12 Krause PJ, Speilman A, Telford SR, Skiand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH: Persistent parasitemia after acute Babesiosis. N Engl J Med. 1998, 339:160-165. A study of 46 individuals with Babesiosis. Patients who did not receive treatment had more evidence of persisting infection than those who did.
13. 13 Hodzic E, Fish D, Maretzki CM, De Silva AM, Feng S, Barthold SW: Acquisition and transmission of the agent of Human Granulocytic Ehrlichiosis by Ixodes scapularis ticks. J Clin Micro 1998, 36:3574-3578.
14. 14 Hofmeister KK, Kolbert CP, Abdulkarim AS, Magera JMH, Hopkins MK, Uhl JR, Ambyaye A, Telford SR, Cockerill FR, Persing DH: Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti, in Permyscus leucopus. J Infect Dis 1998, 177:409-416.
15. 15 Horowitz HW, Aguero-Rosenfeld M, Dumier JS, McKenna DF, Hsieh T, Wu J, Schwartz I, Wormser GP: Reinfection with the agent of Human Granulocytic Ehrlichiosis. Ann Int Med 1998, 129:461-463. A case report of reinfection with the agent of HGE after successful treatment of an initial infection.
16. 16 Wallace BJ, Brady G, Ackman DM, Wong SJ, Jacquette G, Lloyd EE, Birkhead GS: Human Granulocytic Ehrlichiosis in New York. Arch Intern Med 1998, 158:769-773.
17. 17 Magnarelli LA, Ijdo JW, J.F. A, Padula SJ, Flavell RA, Fikrig E: Human exposure to a Granulocytic Ehrlichia and other tick-borne agents in Connecticut. J Clin Micro 1998, 36:2823-2837.
18. 18 Nadelman RB, Wormser GP: Lyme borreliosis. Lancet 1998, 352:557-565.
19. 19 Evans J: Lyme disease. Curr Opin Rheum 1998, 10:339-346.
20. 20 Masters EJ: Erythema Migrans in the south. Arch Intern Med 1998, 158:2162-2165.
21. 21 Oliver JH, Kollars TM, Chandler RW, James AM, Masters EF, Lane RS, Huey LO: First isolation and cultivation of Borrelia burgdorferi Sensu Lato from Missouri. J Clin Micro 1998, 36:1-5.
22. 22 Kirkland KB, Klimko TB, Meriwether RA, Schriefer M, Levin M, Levine J, Mac Kenzie W, Dennis DT: Erythema Migrans-like rash illness at a camp in North Carolina. Arch Int Med 1998, 157:2635-2641.
23. 23 Robinson TT, Herman L, Birrer RB, Wallis KJ, Sama A: Lyme carditis: a rare presentation in an unexpected setting. Am J Emergency Med 1998, 16:265-269.
24. 24 Bachman DT, Srivastava G: Emergency department presentations of Lyme disease in children. Pediatric Emergency Care 1998, 14:356-361.
25. 25 Stanek G, Klein J, Bittner R, Glogar D: Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 1990, 322:249-252.
26. 26 Gasser R, Dusleag J, Reisinger E, Slauber, R, Feigl, B, Pongratz, S, Klein, W, Furian, C, Peirer, K: Reversal by ceftriaxone of dilated cardiomyopathy Borrelia burgdorferi infection. Lancet 1992, 339:1174-1175.
27. 27 Sangha O, Phillips CB, Fleischmann KE, Wang TJ, Fossel AH, Lew R, Liang MH, Shadick NA: Lack of cardiac manifestations among patients with previously treated Lyme disease. Ann Intern Med 1998, 128:346-353.
28. 28 Halperin JJ: Nervous system Lyme disease. J Neurological Sci 1998, 153:182-191. A nice review of the neurologic manifestations of Lyme disease.
29. 29 Haass A: Lyme neuroborreliosis. Curr Opin Neurol 1998, 11:253-258.
30. 30 Riedel M, Straube A, Schwartz MJ, Wilski B, Muller N: Lyme disease presenting as Tourette's syndrome. Lancet 1998, 351.
31. 31 Kan L, Sood SK, Maytai J: Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 1998, 18:439-441.
32. 32 Albisetti M, Schaer G, Good M, Boltshauser E, Nadal D: Diagnosis value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology 1997, 49:817-824.
33. 33 Dupuis M, Luyasu V, Warscotte L, Bauraind O, Michel M: Lyme disease and facial palsy without pleocytosis. Neurology 1998, 51:648.
34. 34 Garcia-Monco JC, Fenandez Villar B, Calvo J, Benach JL: Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion. J Infect Dis 1990, 161:1187-1193.
35. 35 Belman AL, Reynolds L, Preston T, Postels D, Grimson R, Coyle PK: Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med 1997, 151:1224-1228.
36. 36 Shapiro ED, Gerber MA: Lyme disease and facial nerve palsy: More questions than answers. Arch Pediatr Adolesc Med 1997, 151:1183-1184.
37. 37 Bloom BJ, Wyckoff PM, Meissner C, Steere AC: Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatr Infect Dis J 1998, 17:189-96.
38. 38 Logigian EL, Johnson KA, Kijewski MF, Kaplan RF, Becker JA, Jones KJ, Garada BM, Holman BL, Steere AC: Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 1997, 49:1661-1670.
39. 39 Sigal LH: Musculoskeletal manifestations of Lyme arthritis. Rheum Dis Clin N Amer 1998, 24:323-349.
40. 40 Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL: Lyme disease in children in southeastern Connecticut. N Engl J Med 1996, 335:1270-1274.
41. 41 Gerber MA, Zemel LS, Shapiro ED: Lyme arthritis in children: clinical epidemiology and long-term outcomes. Pediatrics 1998, 102:905-908. A study of 90 children with Lyme arthritis. The majority of children responded well to antibiotics without residual symptoms.
42. 42 Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC: Detection of Borrelia burgdorferi DNA of polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994, 330:229-234.
43. 43 Priem S, Burmester GR, kamradt T, Wolbart K, Rittig MG, Krause A: Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 1997, 57:118-121.
44. 44 Roessner K, Trivdei H, Gaur L, Howard D, Aversa J, Cooper SM, Sigal LH, Budd RC: Biased T-cell antigen receptor repertoire in Lyme arthritis. Infect Immun 1998, 66:1092-1099.
45. 45 Gross DM, Steere AC, Guber BT: T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunology 1998, 160:1022-1028.
46. 46 Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998, 281:703-706. A dominant epitope o OspA for T helper cells cross reacted with an amino acid sequence on human leudocyte function-associated antigen-1 (hLFA-1) and provided supportive evidence that an autoimmune process is responsible for chronic Lyme arthritis.
47. 47 Golightly MG: Lyme borreliosis: Laboratory considerations. Seminars in Neurology 1997, 17:11-16.
48. 48 Sigal LH: Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum 1998, 41:195-204. A good discussion of the value and limitations of testing for Lyme disease.
49. 49 Tugwell P, Dennis DT, Weinstein A, Wells G, Nichol G, Shea B, Hayward R, Lightfoot R, Baker P, Steere AC: Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Am J Med 1997, 127:1106-1108.
50. 50 Nichol G, Dennis DT, Steere AC, Lightfoot R, Wells G, Shea B, Tugwell P. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann Int Med 1998, 128:37-48.
51. 51 Fix AD, R. S, Grant J: Tick bites and Lyme disease in an endemic setting: Problematic use of serologic testing and prophylactic antibiotic therapy. JAMA 1998, 279:206-210. A study of the use of serologic testing and antibiotic therapy for tick bites and Lyme disease by practicing physicians in an endemic area.
52. 52 Barbour AG: Expert advice and patient expectations: Laboratory testing and antibiotics for Lyme disease. JAMA 1998, 279:239-240.
53. 53 Sadziene A, Barbour AG: Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview. Infection 1996, 24:195-202.
54. 54 Kramer MD, Wallich R, Simon MM: The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator. Infection 1996, 24:190-194.
55. 55 Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Drause DS, and the Lyme Disease Vaccine Study Group: Vaccination against Lyme Disease with recombinant Borrelia Burgdorferi Outer-Surface Lipoprotein A with adjuvant. N Engl J Med 1998, 339:209-215. The results of a double-blind, placebo-controlled study of the safety and efficacy of a Lyme disease vaccine using recombinant OspA lipoprotein.
56. 56 Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Malawista SE: The Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium: A vaccine consisting of recombinant Borrelia Burgdorferi Outer-Surface Protein A to prevent Lyme disease. N Engl J Med 1998, 339:216-222. The results of a double-blind, placebo-controlled study of the safety and efficacy of a Lyme disease vaccine using recombinant OspA lipoprotein.
57. 57 Marwick C: Guarded endorsement for Lyme disease vaccine. JAMA 1998, 279:1967-1938.
58. 58 Steigbigel RT, Benach JL: Immunization against Lyme disease - an important first step. N Engl J Med 1998, 339:263-264.
59. 59 Gardner P: Lyme Disease Vaccines. Ann Int Med 1998, 129:583-584.
60. 60 Hayes EB, Dennis DT: Letter to the editor: Immunization against Lyme disease. N Engl J Med 1998, 339:1637.
61. 61 Luger S: Letter to the editor: Immunization against Lyme disease. N Engl J Med 1998, 339:1637-1638.
62. 62 Anderson JR: Letter to the editor: Immunization against Lyme disease. N Engl J Med 1998, 339:1638.